# An Explorative Psoriasis Biomarker Study

> **NCT04394936** · NA · TERMINATED · sponsor: **Centre for Human Drug Research, Netherlands** · enrollment: 37 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Guselkumab
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04394936
- **Lead sponsor:** Centre for Human Drug Research, Netherlands
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-01
- **Primary completion:** 2023-02-22
- **Final completion:** 2023-03-27
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Early termination was initiated as the recruitment of the remaining 14 moderate-to-severe patients stagnated.
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04394936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04394936, "An Explorative Psoriasis Biomarker Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04394936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*